Geneva, Switzerland /Chicago, USA, 19 January 2015 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development and the Dystonia Medical Research ...
from Content Keyword RSS http://ift.tt/1BSdbXo
via IFTTT
from Content Keyword RSS http://ift.tt/1BSdbXo
via IFTTT
No comments:
Post a Comment